DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

NEWS RELEASE

Released: December 16, 2014

Defense Health Program
Department of Defense Alcohol and Substance Abuse Research Program
Upcoming Funding Opportunities

The FY14 Defense Appropriations Act provides $3.6 million (M) to the Department of Defense Alcohol and Substance Abuse Research Program (ASADRP) to support innovative research committed to identifying and developing new medications to improve treatment outcomes for alcohol and substance use disorders (ASUD), especially related to traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

The ASADRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY14 ASADRP Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the Grants.gov website in January 2015. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Consortium Award Investigators at or above the level of Assistant Professor (or equivalent)
  • Single operations center to provide oversight and management of basic research and human clinical trials within the consortium
  • Provide leadership to facilitate collaboration of multiple organizations and individuals with the goal of translating basic science knowledge into enhanced clinical pharmacological treatment protocols for Alcohol and Substance Abuse Disorders
  • Maximum funding of $3,600,000 in direct plus indirect costs
  • Period of performance not to exceed 5 years

All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for the award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Letters of Intent are required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org). Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcement is released. Requests for email notification of the Program Announcement release may be sent to help@eBRAP.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the ASADRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil